NCT05963087 2023-07-27Cetuximab in Combination With Dabrafenib and Tislelizumab in BRAF Mutated Treatment of Advanced Colorectal CancerZhejiang Cancer HospitalPhase NA Not yet recruiting22 enrolled
NCT05928312 2023-07-20Fruquintinib Combined With Chemotherapy as Third-line /Third-line+ Treatment in Advanced Colorectal CancerZhejiang Cancer HospitalPhase NA Not yet recruiting72 enrolled